The Immunomodulatory Aspect of Quercetin Penta Acetate on Th17 Cells Proliferation and Gene Expression in Multiple Sclerosis

Document Type : Original Article

Authors

1 Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

3 Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 Iranian Multiple Sclerosis and Neuroimmunology Research Center, Isfahan, Iran

Abstract

Objective: The function of Th17 cells in the neuroinflammatory process in multiple sclerosis (MS) has been previously
clarified. It has been suggested that Quercetin can influence MS due to a variety of anti-inflammatory effects. The present
study aimed to examine in vitro immunomodulatory aspects of Quercetin Penta Acetate as a modified compound on
Th17 cells of MS patients and also to compare its effects with Quercetin.
Materials and Methods: In this experimental study, peripheral blood mononuclear cell (PBMCs) were isolated and
stained with CFSE then, half-maximal inhibitory concentration (IC50) values were determined using different doses
and times for Quercetin Penta Acetate, and Methyl Prednisolone Acetate. Th17 cell proliferation was analyzed by flow
cytometry and the expression levels of IL-17 and RORc genes were assessed by real-time polymerase chain reaction
(PCR) method.
Results: The results showed that IL-17A gene expression was inhibited by Quercetin Penta Acetate (P=0.0081), but
Quercetin Penta Acetate did not have a significant inhibitory effect on Th17 cells proliferation (P= 0.59) and RORc gene
expression (P=0.1), compared to Quercetin.
Conclusion: Taken together, our results showed some immunomodulatory aspects of Quercetin Penta Acetate on
Th17 cells are more effective than Quercetin and it could be considered in the treatment of MS.

Keywords

References

  1. Jadidi-Niaragh F, Mirshafiey A. Th17 cell, the new player of neuroinflammatoryprocess in multiple sclerosis. Scand J Immunol. 2011; 74(1): 1-13.
  2. Khan D, Ansar Ahmed S. Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs. Front Genet. 2015; 6: 236.
  3. Wienke J, Janssen W, Scholman R, Spits H, van Gijn M, Boes M, et al. A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation. Oncotarget. 2015; 6(24): 20037- 20042.
  4. Ahmadi M, Yousefi M, Abbaspour-Aghdam S, Dolati S, Aghebati- Maleki L, Eghbal-Fard S, et al. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet’s disease. J Cell Physiol. 2019; 234(4): 3985-3994.
  5. Milo R, Miller A. Revised diagnostic criteria of multiple sclerosis. Autoimmun Rev. 2014; 13(4-5): 518-524.
  6. Notoya M, Tsukamoto Y, Nishimura H, Woo JT, Nagai K, Lee IS, et al. Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro. Eur J Pharmacol. 2004; 485(1-3): 89-96.
  7. Kelly GS. Quercetin. Monograph. Altern Med Rev. 2011; 16(2): 172-194.
  8. Costa LG, Garrick JM, Roquè PJ, Pellacani C. Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more. Oxid Med Cell Longev. 2016; 2016: 2986796.
  9. Ginwala R, Bhavsar R, Chigbu DI, Jain P, Khan ZK. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants (Basel). 2019; 8(2): 35.
  10. Biharee A, Sharma A, Kumar A, Jaitak V. Antimicrobial flavonoids as a potential substitute for overcoming antimicrobial resistance. Fitoterapia. 2020; 146: 104720.
  11. Wang Y, Li W, Wang M, Lin C, Li G, Zhou X, et al. Quercetin reduces neural tissue damage and promotes astrocyte activation after spinal cord injury in rats. J Cell Biochem. 2018; 119(2): 2298-2306.
  12. Sternberg Z, Chadha K, Lieberman A, Hojnacki D, Drake A, Zamboni P, et al. Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients. J Neuroimmunol. 2008; 205(1-2): 142- 147.
  13. Islam MS, Quispe C, Hossain R, Islam MT, Al-Harrasi A, Al-Rawahi A, et al. Neuropharmacological effects of quercetin: a literaturebased review. Front Pharmacol. 2021; 12: 665031.
  14. Grande F, Parisi OI, Mordocco RA, Rocca C, Puoci F, Scrivano L, et al. Quercetin derivatives as novel antihypertensive agents: Synthesis and physiological characterization. Eur J Pharm Sci. 2016; 82: 161-170.
  15. Khosa A, Saha RN, Singhvi G. Drug delivery to the brain. In: Grumezescu AM, editor. Nanomaterials for drug delivery and therapy. New York: Elsevier; 2019: 461-514.
  16. Scottà C, Fanelli G, Hoong SJ, Romano M, Lamperti EN, Sukthankar M, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica. 2016; 101(1): 91-100.
  17. Rahmati M, Ghannadian SM, Kasiri N, Ahmadi L, Motedayyen H, Shaygannejad V, et al. Modulation of Th17 proliferation and IL 17A gene expression by acetylated form of apigenin in patients with multiple sclerosis. Immunol Invest. 2021; 50(2-3): 216-229.
  18. Andrade PB, Grosso C, Valentao P, Bernardo J. Flavonoids in neurodegeneration: limitations and strategies to cross CNS barriers. Curr Med Chem. 2016; 23(36): 4151-4174.
  19. Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. Quercetin, inflammation and immunity. Nutrients. 2016; 8(3): 167.
  20. Wang K, Song F, Fernandez-Escobar A, Luo G, Wang JH, Sun Y. The properties of cytokines in multiple sclerosis: pros and cons. Am J Med Sci. 2018; 356(6): 552-560.
  21. Muthian G, Bright JJ. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J Clin Immunol. 2004; 24(5): 542-552.
  22. Cao L, Yang Y, Ye Z, Lin B, Zeng J, Li C, et al. Quercetin3methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways. Int J Mol Med. 2018; 42(3): 1625-1636.
  23. Khorsandi L, Orazizadeh M, Niazvand F, Abbaspour MR, Mansouri E, Khodadadi A. Quercetin induces apoptosis and necroptosis in MCF-7 breast cancer cells. Bratisl Lek Listy. 2017; 118(2): 123-128.
  24. Yang Y, Bai L, Li X, Xiong J, Xu P, Guo C, et al. Transport of active flavonoids, based on cytotoxicity and lipophilicity: an evaluation using the blood-brain barrier cell and Caco-2 cell models. Toxicol In Vitro. 2014; 28(3): 388-396.
  25. Tosi G, Duskey JT, Kreuter J. Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opin Drug Deliv. 2020; 17(1): 23-32.
  26. Md S, Bhattmisra SK, Zeeshan F, Shahzad N, Mujtaba MA, Meka VS, et al. Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. J Drug Deliv Sci Technol. 2018; 43: 295-310.
  27. Dos Passos GR, Sato DK, Becker J, Fujihara K. Th17 cells pathways in multiple sclerosis and neuromyelitis optica spectrum disorders: pathophysiological and therapeutic implications. Mediators Inflamm. 2016; 2016: 5314541.
  28. Siard MH, McMurry KE, Adams AA. Effects of polyphenols including curcuminoids, resveratrol, quercetin, pterostilbene, and hydroxypterostilbene on lymphocyte pro-inflammatory cytokine production of senior horses in vitro. Vet Immunol Immunopathol. 2016; 173: 50-59.
  29. Albegova DZ, Kamkina OV, Pavlova SI, Albegova ZhK, Laptev OS, Kozlov IG. Evaluation of the effect of modified bioflavonoid and quercetin dihydrate on cytokine secretion by mitogen-activated mononuclear cells. Bull Exp Biol Med. 2015; 159(5): 626-628.
  30. Miljković Z, Momcilović M, Miljković D, Mostarica-Stojković M. Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis. J Neuroinflammation. 2009; 6: 37.
  31. Liu M, Hu X, Wang Y, Peng F, Yang Y, Chen X, et al. Effect of highdose methylprednisolone treatment on Th17 cells in patients with multiple sclerosis in relapse. Acta Neurol Scand. 2009; 120(4): 235-241.
  32. Lee KM, Kang JH, Yun M, Lee SB. Quercetin inhibits the poly(dA:dT)-induced secretion of IL-18 via down-regulation of the expressions of AIM2 and pro-caspase-1 by inhibiting the JAK2/ STAT1 pathway in IFN-γ-primed human keratinocytes. Biochem Biophys Res Commun. 2018; 503(1): 116-122.
Cell Journal (Yakhteh)
Volume 25, Issue 2 - Serial Number 109
February 2023
Pages 110-117

Files

Cited by

Share

How to cite

Statistics